Clinical Trial Update: Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating carboplatin/paclitaxel in combination with pembrolizumab for locoregionally advanced penile cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Cancer
• Penile Squamous Cell Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Urologic Neoplasms, Urogenital Neoplasms | Phase 2 | Status: RECRUITING